Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis
Therapeutic Apheresis and Dialysis · 2024
DOI: 10.1111/1744-9987.14065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2024. Verfasst von Shingo Konno und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan. Hauptthemen laut MEDLINE: Myasthenia Gravis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objectives
The aim of the study was to investigate the serological factors in predicting symptom improvement in myasthenia gravis (MG) patients who underwent plasmapheresis (PP).
Methods
The relationship between symptom improvement and change in immunoglobin G (IgG) and acetylcholine receptor antibody (AchR‐Ab) levels in 21 MG patients after PP was analyzed.
Results
Patients were divided into two groups: the favorable ( n = 11) or unfavorable ( n = 10) response groups around the median MG composite improvement rate (50 [29, 56]%) 2 weeks after a PP course. In all patients, the IgG reduction rate before and after PP was higher in the favorable than the unfavorable response group. In AChR‐Ab‐positive patients, IgG and AChR‐Ab reduction rates were higher in the favorable than the unfavorable response group.
Conclusion
IgG reduction rate is a predictor of symptom improvement in MG patients who underwent PP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Toho University Ohashi Medical Center, Tokyo, Japan.
ORCID-Profile: Shingo Konno
Zitieren
APA
Konno, S., & Fujioka, T. (2024). Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14065
Vancouver
Konno S, Fujioka T. Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis. Therapeutic Apheresis and Dialysis. 2024. doi:10.1111/1744-9987.14065
BibTeX
@article{Konno2024,
author = {Konno, Shingo and Fujioka, Toshiki},
title = {Serum immunoglobulin G level reduction is a predictor of short‐term improvement in patients with myasthenia gravis undergoing plasmapheresis},
journal = {Therapeutic Apheresis and Dialysis},
year = {2024},
doi = {10.1111/1744-9987.14065}
}
EUVIMED